Condition
Human Immunodeficiency Viruses
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
1Total
P 3 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT01976715Completed
Study of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral Therapy
NCT05294159CompletedPrimary
Implementing Long-Acting Novel Antiretrovirals
NCT00933933Phase 3CompletedPrimary
Evaluation of Diagnostic HIV Ag/Ab Combo Assay
NCT00551655CompletedPrimary
Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients
Showing all 4 trials